optimizing cns prophylaxis in the treatment of all
Published 8 months ago • 60 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:00
unmet needs in bpdcn: cns involvement & the importance of intrathecal chemotherapy prophylaxis
-
1:03
the need to improve management and treatment strategies for secondary cns lymphoma
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
0:58
current research and next steps to improve the understanding and management of icaht
-
2:00
optimizing hma treatment in hr-mds: azacitidine versus decitabine
-
8:01
lncrnalyzr: lncrna enrichment analysis app
-
43:40
optimized and scalable lnp composition for rna vaccine delivery
-
56:54
ensuring viral safety in cell & gene therapy through next-generation sequencing
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
2:42
optimizing biological agents for all
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
1:36
chemotherapy and allohsct in the treatment of all
-
2:10
optimizing car-t therapy in lbcl
-
1:46
optimizing conditioning regimens in patients with aml undergoing allosct
-
2:35
methods of optimizing transplantation in mds
-
1:02
the challenge of treating bpdcn in a resource-limited setting
-
3:29
ptcy as gvhd prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
-
2:12
barriers to the implementation and standardization of ai in the clinic
-
1:18
the epidemiology and treatment of chronic gvhd post-allosct
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment